What's so special about the developing immune system?

International Journal of Toxicology

Volumn 27, Issue 2, 2008, Pages 223-254

  Burns Naas, Leigh Ann ^a   Hastings, Kenneth L ^b   Ladics, Gregory S ^c   Makris, Susan L ^d   Parker, George A ^e   Holsapple, Michael P ^f  

^a PFIZER INC   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c DUPONT COMPANY   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^e WIL Biotechnics LLC   (United States)

^f ILSI HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE   (United States)

Author keywords

Developmental Immunotoxicology; DIT; Immune Development Immune System; Immune Testing; Immunopathology

Indexed keywords

ENVIRONMENTAL CHEMICAL; PESTICIDE; TOXIC SUBSTANCE;

AUTOPSY; DEVELOPMENTAL IMMUNOTOXICOLOGY; DEVELOPMENTAL STAGE; EXPERIMENTAL MODEL; FUNCTIONAL ANATOMY; FUNCTIONAL ASSESSMENT; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNE SYSTEM; IMMUNOLOGICAL PARAMETERS; IMMUNOPATHOLOGY; IMMUNOTOXICITY; NONHUMAN; ORGAN WEIGHT; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; TOXICITY TESTING; TOXICOLOGY;

ANIMALS; HUMANS; IMMUNE SYSTEM; ORGAN SIZE; RISK ASSESSMENT;

ANIMALIA;

EID: 42049095775     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810801978110     Document Type: Review

References (130)

1. Ackinbami, L. J., and K. C. Schroendorf. 2002. Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics 110:315-322.
2. Barnett, J. B. 1996. Developmental immunotoxicology. In Experimental Immunotoxicology, ed. M. P. Holsapple and R. J. Smialowicz, 47-62. Boca Raton, FL: CRC Press.
3. Barnett, J. B., L. F. Gibson, and K. S. Landreth. 2005. Developmental immunotoxicity of chlordane. In Developmental Immunotoxicology, ed. S. D. Holladay 153-168. Boca Raton, FL: CRC Press.
4. Besteman, E. G., K. L. Zimmerman, and S. D. Holladay. 2005. Diethylstilbestrol (DES)-induced fetal thymic atrophy in C57BL/6 mice: Inhibited thymocyte differentiation and increased apoptotic cell death. Int. J. Toxicol. 24:231-239.
5. Bjorkman, N., and V. Dantzer. 1987. Placentation. In Textbook of Veterinary Histology, 340-360. Philadephia: Lea & Febier.
6. Blümer, N., P. I. Pfefferle, and H. Renz. 2007. Development of mucosal immune function in the intrauterine and early postnatal environment. Curr. Opin. Gastroenterol. 23:655-660.
7. Bunn, T. L., G. S. Ladics, M. P. Holsapple, and R. R. Dietert. 2001. Developmental immunotoxicity assessment in the rat: Age, gender, and strain comparisons after exposure to lead. Toxicol. Methods 11:41-58.
8. Bunn, T. L., P. J. Parsons, E. Kao, and R. R. Dietert. 2001. Exposure to lead during critical windows of embryonic development: differential immunotoxic outcome based on stage of exposure and gender. Toxicol. Sci. 64:57-66.
9. Burns-Naas, L. A., B. J. Meade, and A. E. Munson. 2001. Toxic responses of the immune system. In Casarett & Doull's toxicology, the basic science of poisons, ed. C. D. Klaassen, 419-470. New York: McGraw-Hill.
10. Burns-Naas, L. A., R. J. Dearman, D. R. Germolec, N. E. Kaminski, I. Kimber, G. S. Ladics, R. W. Luebke, J. C. Pfau, and S. B. Pruett. 2006. "Omics" technologies and the immune system. Toxicol. Mech. Methods 16:101-119.
11. Buse, E. 2005. Development of the immune system in the cynomolgus monkey: The appropriate model in human targeted toxicology? J. Immunotoxicol. 2:211-216.
12. Buse, E., G. Habermann, I. Osterburg, R. Korte, and G. F. Weinbauer. 2003. Reproductive/developmental toxicity and immunotoxicity assessment in the nonhuman primate. Toxicology 221:221-227.
13. Carney, E. W., C. L. Zablotney, M. S. Marty, J. W. Crissman, P. A. Anderson, M. Woolhiser, and M. Holsapple. 2004. The effects of feed restriction during in utero and postnatal development in rats. Toxicol Sci. 82:237-249.
14. Cesta, M. F. 2007a. Normal structure, function, and histology of the spleen. Toxicol. Pathol. 34:455-465.
15. Cesta, M. F. 2007b. Normal structure, function, and histology of mucosa-associated lymphoid tissue. Toxicol. Pathol. 34:599-608.
16. Cooper, R. L., J. C. Lamb, S. M. Barlow, K. Bentley, A. M. Brady, N. G. Doerrer, D. L. Eisenbrandt, P. A. Fenner-Crisp, R. N. Hines, L. F. H. Irvine, C. A. Kimmel, H. Koeter, A. A. Li, S. L. Makris, L. P. Sheets, G. J. A. Speijers, and K. E. Whitby. 2006. A tiered approach to life stages testing for agricultural chemical safety assessment. Crit. Rev. Toxicol. 36:69-98.
17. Dallaire, F., E. Dewailly, C. Vezina, G. Muckle, J. P. Weber, S. Bruneau, and P. Ayotte. 2006. Effect of prenatal exposure to polychlorinated biphenyls on incidence of acute respiratory infections in preschool Inuit children. Environ. Health Perspect. 114(8):1301-1305.
18. Dietert, R. R., and M. Holsapple. 2006. Methodologies for developmental immunotoxicity (DIT) testing. Methods 41:123-131.
19. Dietert, R. R., R. A. Etzel, D. Chen, M. Halonen, S. D. Holladay, A. M. Jarabek, K. Landreth, D. B. Peden, K. Pinkerton, R. J. Smialowicz, and T. Zoetis. 2000. Workshop to identify critical windows of exposure for children's health: Immune and Respiratory Systems Work Group Summary. Environ. Health Perspect. 108(Suppl. 3):483-490.
20. Dietert, R. R., J. E. Lee, and T. L. Bunn. 2002. Developmental immunotoxicology: Emerging issues. Hum. Exp. Toxicol. 21:479-485.
21. Dietert, R. R., J. E. Lee, J. Olsen, K. Fitch, and J. A. Marsh. 2003. Developmental immunotoxicity of dexamethasone: Comparison of fetal versus adult exposures. Toxicology 194:163-176.
22. Dietert, R. R., J. E. Lee, I. Hussain, and M. Piepenbrink. 2004. Developmental immunotoxicology of lead. Toxicol. Appl. Pharmacol. 198:86-94.
23. Dietert, R. R., and M. S. Piepenbrink. 2006a. Perinatal Immunotoxicity: Why adult exposure assessment fails to preduct risk. Environ. Health Perspect. 114:477-483.
24. Dietert, R. R., and M. S. Piepenbrink. 2006b. Lead and immune function. Crit. Rev. Toxicol. 36:359-385.
25. Dunn, T. 1954. Normal and pathologic anatomy of the reticular tissue in laboratory mice. J. Natl. Cancer Inst. 14:1281-1433.
26. Edwards, C. J., and C. Cooper. 2006. Early environmental factors and rheumatoid arthritis. Clin. Exp. Immunol.143:1-5.
27. Elmore, S. A. 2007a. Histopathology of the lymph nodes. Toxicol. Pathol. 34:425-454.
28. Elmore, S. A. 2007b. Enhanced histopathology of the lymph nodes. Toxicol. Pathol. 34:634-647.
29. Elmore, S. A. 2007c. Enhanced histopathology of the spleen. Toxicol. Pathol. 34:648-655.
30. Elmore, S. A. 2007d. Enhanced histopathology of the thymus. Toxicol. Pathol. 34:656-665.
31. Elmore, S. A. 2007e. Enhanced histopathology of the bone marrow. Toxicol. Pathol. 34:6666-686.
32. Elmore, S. A. 2007f. Enhanced histopathology of mucosa-associated lymphoid tissue. Toxicol. Pathol. 34:6687-696.
33. EMEA (European Medicines Agency, Committee for Human Medicinal Products). 2005. Guideline on the need for non-clinical testing in juvenile animals on human pharmaceuticals for paediatric indications (Draft). EMEA/CHMP/SWP/169215/ 2005.
34. Enders, A. C., and A. M. Carter. 2004. What can comparative studies of placental structure tell us? A review. Placenta 25(Suppl. A, Trophoblast Res. Vol. 18):S3-S9.
35. EPA(United States Environmental Protection Agency). 1991. Guidelines for developmental toxicity risk assessment. Fed Registrar 56:63798-63826. Available at http://www.epa.gov/ncea/raf/.
36. EPA (United States Environmental Protection Agency). 1996. Guidelines for reproductive toxicity risk assessment. 630/R-96/009. EPA Risk Assessment Forum, Washington, DC. Available at http://cfpub.epa.gov/ncea/raf/recordisplay.cfm? deid=2838
37. EPA (United States Environmental Protection Agency). 1997. Tributyltin oxide (CAS no. 56-35-9): Toxicological review in support of summary information on the Integrated Risk Information System (IRIS). Available at http://www.epa.gov/iris/toxreviews/0349-tr.pdf
38. EPA (United States Environmental Protection Agency). 1998. Guidelines for neurotoxicity risk assessment. 630/R-95/001F. EPA Risk Assessment Forum, Washington, DC. Available at http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm? deid=12479
39. EPA (United States Environmental Protection Agency). 2002a. A review of the reference dose and reference concentration processes. EPA/630/P-02/002F, EPA Risk Assessment Forum, Washington, DC. Available at http://cfpub.epa.gov/ncea/ cfm/recordisplay.cfm?deid=55365
40. EPA (United States Environmental Protection Agency). 2002b. Determination of the appropriate FQPA Factors(s) in tolerance assessment. EPA, Office of Pesticide Programs, Washington, DC. Available at http://www.epa.gov/oppfead1/ trac/science/determ.pdf
41. EPA (United States Environmental Protection Agency). 2005. Guidelines for carcinogen risk assessment. EPA/630/P-03/001F, EPA Risk Assessment Forum, Washington, DC. Available at http://cfpub.epa.gov/ncea/raf/recordisplay.cfm? deid=116283
42. Fahy, O., S. Senechal, J. Pene, A. Scherpereel, P. Lassalle, A. B. Tonnel, H. Yssel, B. Wallaert, and R. Tsicopoulos. 2002. Diesel exhaust favors Th2 cell recruitment by mononuclear cells and alveolar macrophage-derived chemokine on INF-induced protein-10 production. J. Immunol. 168:5912-5919.
43. FDA (United States Food and Drug Administration). 2002. Guidance for Industry- Immunotoxicology evaluation of investigational new drugs. Office of Training and Communication, Division of Drug Information, Center for Drug Evaluation and Research, U.S. Department of Health and Human Services.
44. Felsburg, P. J. 2002. Overview of immune system development in the dog: Comparison with humans. Human Exp. Toxicol. 21:487-492.
45. Gehrs, B. C., and R. J. Smialowicz. 1999. Persistent suppression of delayed-type hypersensitivity in adult F344 rats after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology 134:79-88.
46. Germolec, D. R., M. Kashon, A. Nyska, C. F. Kuper, C. Portier, C. Kommineni, K. A. Johnson, and M. I. Luster. 2004. The accuracy of extended histopathology to detect immunotoxic chemicals. Toxicol. Sci. 82:504-514.
47. Guo, T. L., D. R. Germolec, D. L. Musgrove, K. B. Delclos, R. R. Newbold, C. Weis, and K. L. White, Jr. 2005. Myelotoxicity in genistein-, nonylphenol-, methoxychlor-, vinclozolin, or ethinyl estradiol-exposed F1 generations of Sprague-Dawley rats following developmental and adult exposures. Toxicology 211:207-219.
48. Haggqvist, B., S. Havarinaseb, E. Bjorn, and P. Hultman. 2005. The immunosuppressive effect of methylmercury does not preclude development of autoimmunity in genetically susceptible mice. Toxicology 208:149-164.
49. Haley, P. J. 2003. Species differences in the structure and function of the immune system. Toxicology 188:49-71.
50. Haley, P., R. Perry, D. Ennulat, S. Frame, C. Johnson, J. M. Lapointe, A. Nyska, P. Snyder, D. Walker, G. Walter. 2005. STP position paper: Best practice guideline for the routine pathology evaluation of the immune system. Toxicol. Pathol. 33:404-408.
51. Heilmann, C., P. Grandjean, P. Weihe, F. Neilsen, and E. Budtz-Jorgensen. 2006. Reduced antibody responses to vaccinations in children exposured to polychlorinated biphenyls. PLoS Med. 3:1352-1359.
52. Hendrickx, A. G., N. Makori, and P. Peterson. 2002. The nonhuman primate as a model of developmental immunotoxicity. Human Exp. Toxicol. 21:537-542.
53. Hendrickx, A. G., P. E. Peterson, and N. M. Makori. 2005. The nonhuman primate as a model of developmental immunotoxicity. In Developmental Immunotoxicology, ed. S. D. Holladay 117-136. Boca Raton, FL: CRC Press.
54. Hinton, D. M. 2000. "Redbook"; immunotoxicity testing guidelines and research in immunotoxicity evaluations of food chemicals and new food proteins. Toxicol. Pathol. 28:467-78.
55. Holladay, S. D., and B. L. Blalock. 2002. Mouse as a model for developmental immunotoxicology. Human Exp. Toxicol. 21:525-531.
56. Holladay, S. D., and R. J. Smialowicz. 2000. Development of the murine and human immune system: differential effects of immunotoxicants depend on time of exposure. Environ. Health Perspect. 108(Suppl. 3):463-473.
57. Holsapple, M. P. 1995. The plaque-forming cell (PFC) response in Immunotoxicology: an approach to monitoring the primary effect function of B lymphocytes. Methods Immunotoxicol. 1:150-176.
58. Holsapple, M. P. 2002. Developmental immunotoxicology and risk assessment: A workshop summary. Human Exp. Toxicol. 21:473-478.
59. Holsapple, M. P., L. A. Burns-Naas, K. Hastings, G. S. Ladics, A. L. Lavin, S. Makris, Y. Yang, and M. I. Luster. 2005. A proposed testing framework for developmental immunotoxicology (DIT). Toxicol. Sci. 83:18-24.
60. Holsapple, M. P., D. J. Paustenbach, G. Charnley, L. J. West, M. I. Luster, R. R. Dietert, and L. Burns-Naas. 2004. Symposium summary: Children's Health Risk - What's so special about the developing immune system?. Toxicol. Appl. Pharmacol. 199:61-70.
61. Holsapple, M. P., J. W. van der Laan, and H. van Loveren. 2007. Development of a framework for developmental immunotoxocity (DIT) testing. In Immunotoxicology and Immunopharmacology, 3rd ed., ed. R. Luebke, R. House, and I. Kimber, 347-361. Boca Raton, FL: CRC Press.
62. Holsapple, M. P., L. J. West, and K. S. Landreth. 2003. Species comparison of anatomical and functional immune system development. Birth Defect Res. B 68:321-334.
63. Holt, P. G., J. Rowe, R. Loh, and P. D. Sly. 2003. Developmental factors associated with risk for atopic disease: implications for vaccine strategies in early childhood. Vaccine. 21:3432-3435.
64. Hrubec, T. G., B. L. Blalock, and S. D. Holladay. 2005. Developmental immunotoxicity of halogenated aromatic hydrocarbons and polycyclic aromatic hydrocarbons. In Developmental Immunotoxicology, ed. S. D. Holladay, 139-152. Boca Raton, FL: CRC Press.
65. Holt, P., J. W. Upshaw, and P. D. Sly. 2005. J. Allergy Clin. Immunol. 116:16-24.
66. Hussain, I., M. S. Piepenbrink, K. J. Fitch, J. A. Marsh, and R. R. Dietert. 2005. Developmental immunotoxicity of cyclosporin-A in rats: Age-associated differential effects. Toxicology 206:273-284.
67. Itazawa, T., Y. Adachi, Y. Okabe, M. Hamamichi, Y. S. Adachi, M. Toyoda, M. Morohashi, and T. Miyawaki. 2003. Developmental changes in interleukin-12-producing ability by monocytes and their relevance to allergic diseases. Clin. Exp. Allergy 33:525-530.
68. Immunotoxicology Technical Committee (ITC), and J. D. Sandler. 2002. Executive summary. Hum. Exp. Toxicol. 21: 469-471.
69. Karpuzoglu-Sahin, E., B. D. Hissong, and A. S. Ansar. 2001. Interferon-gamma levels are upregulated by 17-beta-estradiol and diethylstilbestrol. J. Reprod. Immunol. 52:113-127.
70. Karrow, N. A., T. L. Guo, K. B. Declos, R. R. Newbold, C. Weis, D. R. Germolec, K. L. White Jr., and J. A. McCay. 2005. Nonylphenol alters the activity of splenic NK cells and the numbers of leukocyte subpopulations in Sprague-Dawley rats: A two-generation feeding study. Toxicology 196:237-345.
71. Keil, D. E. 2007. Immunotoxicology of jet propulsion fuel-8. In Immunotoxicology and Immunopharmacology, 3rd ed., ed. R. Luebke, R. House, and I. Kimber, 232-233. Boca Raton, FL: CRC Press.
72. Kiecolt-Glaser, J. K., L. McGuire, T. F. Robles, and R. Glaser. 2002. Psychoneuroimmunology: Psychological influences on immune function and health. J. Consult. Clin. Psychol. 70:537-547.
73. Kimmel, C. A., M. D. King, and S. L. Makris. 2005. Risk assessment perspectives for developmental immunotoxicity. In Developmental Immunotoxicology, ed. S. D. Holladay, 45-63. Boca Raton, FL: CRC Press.
74. Krampera, M., F. Vinante, L. Tavecchia, L. Morosato, M. Chilosi, S. Romagnani, M. E. Zanolin, and G. Pizzolo. 1999. Progressive polarization towards a T helper/cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration. Clin. Exp. Immunol. 117:291-297.
75. Kuper, C. F. 2007. Histopathology of mucosa-associated lymphoid tissue. Toxicol. Pathol. 34:609-615.
76. Kuper, C. F., J. H. Harleman, et al. 2000. Histopathologic approaches to detect changes indicative of immunotoxicity. Toxicol Pathol. 28:454-466.
77. Kuper, C., H. Schuurman, et al. 1995. Pathology in immunotoxicology. Methods Immunotoxicol. 1:397-436.
78. Ladics, G. S., R. E. Chapin, K. L. Hastings, M. P. Holsapple, S. L. Makris, L. P. Sheets, M. R. Woolhiser, and L. A. Burns-Naas. 2005. Developmental toxicology evaluations: Issues with including neurotoxicology and immunotoxicology assessments in reproductive toxicology studies. Toxicol. Sci. 88:24-29.
79. Ladics, G. S., C. Smith, T. L. Bunn, R. R. Dietert, P. K. Anderson, C. M. Wiescinski, and M. P. Holsapple. 2000. Characterization of an approach to developmental Immunotoxicology assessment in the rat using SRBC as the antigen. Toxicol. Methods 10:283-311.
80. Lamason, R., P. Zhao, R. Rawat, A. Davis, J. C. Hall, J. J. Chae, R. Agarwal, P. Cohen, A. Rosen, E. P. Hoffman, and K. Nagaraju. 2006. Sexual dimorphism in immune response genes as a function of puberty. BMC Immunol. 7:2; http://biomedcentral.com/1471-2172/7/2.
81. Landreth, K. S. 2002. Critical windows in development of the rodent immune system. Human Exp. Toxicol. 21:493-498.
82. Leonardi, S., M. M. del Giudice, M. La Rossa, and J. A. Bellanti. 2007. Atopic disease, immune system, and the environment. Allergy Asthma Proc. 28:410-417.
83. Lim, K. J., O. A. Odukoya, R. A. Ajjan, T. C. Li, A. P. Weetman, and I. D. Cook. 2000. The role of T helper cytokines in human reproduction. Fertil Steril. 73:136-142.
84. Liu, A. H. 2007. Hygiene theory and allergy and asthma prevention. Paediatr. Perinatal Epidemiol. 21(Suppl. 3):2-7.
85. Luebke, R. W., D. H. Chen, R. Dietert, Y. Yang, M. King, and M. I. Luster. 2006. The comparative immunotoxicity of five selected compounds following developmental or adult exposure. J. Toxicol. Environ. Health Crit. Rev. 9:1-26.
86. Luebke, R. W., M. P. Holsapple, G. S. Ladics, M. I. Luster, M. J. Selgrade, R. J. Smialowicz, M. R. Woolhiser, and D. R. Germolec. 2006. Immunotoxicogenomics: The potential of genomics technology in the immunotoxicity risk assessment process. Toxicol Sci. 94:22-27.
87. Luster, M. I., J. H. Dean, and D. R. Germolec. 2003. Consensus workshop on methods to evaluate developmental Immunotoxicity. Environ. Health Perspect. 111:579-583.
88. Luster, M. I., V. J. Johnson, B. Yucesoy, and P. P. Simeonova. 2005. Biomarkers to assess potential developmental immunotoxicity in children. Toxicol. Appl. Pharmacol. 206:229-236.
89. Luster, M. I., A. Munson, P. T. Thomas, M. P. Holsapple, J. D. Fenters, K. L. White Jr., L. D. Lauer, D. R. Germolec, G. J. Rosenthal, and J. H. Dean. 1988. Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice. Fundam. Appl. Toxicol. 10:2-19.
90. Luster, M. I., C. Portier, D. G. Pait, G. J. Rosenthal, D. R. Germolec, E. Corsini, B. L. Blaylock, P. Pollock, Y. Kouchi, W. Craig, K. L. White Jr., A. E. Munson, and C. E. Comment. 1993. Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests. Fundam. Appl. Toxicol. 21:71-82.
91. Luster, M. I., C. Portier, D. G. Pait, K. L. White Jr., C. Gennings, A. E. Munson, and G. J. Rosenthal. 1992. Risk assessment in immunotoxicology. I. Sensitivitiy and predictability of immune tests. Fundam. Appl. Toxicol. 18:200-210.
92. Maronpot, R. R. 2007a. A monograph on histomorphologic evaluation of lymphoid organs. Toxicol. Pathol. 34:407-408.
93. Maronpot, R. R. 2007b. Enhanced histopathology of lymphoid tissues. Toxicol. Pathol. 34:631-633.
94. Miller, G. K., and S. A. Benjamin. 1985. Radiation-induced quantitative alterations in prenatal thymic development in the beagle dog. Lab Invest. 52:224-231.
95. Miller, T. E., K. A. Golemboski, H. A. Ha, T. L. Bunn, F. S. Sanders, and R. R. Dietert. 1998. Developmental exposure to lead causes persistent immunotoxicity in Fischer 344 rats. Toxicol. Sci. 42:129-135.
96. Moffett, A., and C. Loke. 2006. Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 6:584-595.
97. Moser, V. S., I. Walls, and T. Zoetis. 2005. Direct dosing of preweaning rodents in toxicity testing and research: deliberations of an ILSI RSI expert working group. Int. J. Toxicol. 24:87-94.
98. National Research Council (NRC). 1993. Pesticides in the diets of infants and children. Washington, DC: National Academy Press.
99. Neubert, R. T., J. R. Webb, and D. Neubert. 2002. Feasibility of human trials to assess developmental Immunotoxicity, and some comparison with data on New World monkeys. Human Exp. Toxicol. 21:543-567.
100. Ota, M. O., J. Vekemans, S. E. Schlegel-Haueter, K. Fielding, H. Whittle, P. H. Lambert, K. P. McAdam, C. A. Siegrist, and A. Marchant. 2004. Hepatitis B immunization induces higher antibody and memory Th2 responses in newborns than in adults. Vaccine 22:511-519.
101. Ovsyannikiva, I. G., K. C. Reid, R. M. Jacobson, A. L. Oberg, G. G. Klee, and G. A. Poland. 2003. Cytokine production patterns and antibody response to measles vaccine. Vaccine 21:3946-3953.
102. Parker, G. A. and C. A. Picut. 2005. Liver immunobiology. Toxicol Pathol. 33:52-62.
103. Pearse, G. 2007a. Normal structure, function and histology of the thymus. Toxicol. Pathol. 34:504-514.
104. Pearse, G. 2007b. Histopathology of the thymus. Toxicol. Pathol. 34:515-547.
105. Protonotariou, E., A. Malamitsi-Puchner, D. Rizos, A. Sarandakou, E. Makrakis, and E. Salamolekis. 2003. Alterations in TH1/TH2 cytokine concentrations in early neonatal life. J. Matern. Fetal Neonatal Med. 14:407-410.
106. Rowe, J., C. Macaubas, T. Monger, B. J. Holt, J. Harvey, J. T. Poolman, R. Loh, P. D. Sly, and P. G. Holt. 2001. Heterogeneity in diphtheria-tetanus- acellular pertussis vaccine-specific cellular immunity during infancy: Relationship to variations in the kinetics of postnatal maturation of systemic th1 function. J. Infect. Dis. 184:80-88.
107. Scharer, K. 1977. The effect of chronic underfeeding on organ weights of rats. How to interpret organ weight changes in cases of marked growth retardation in toxicity tests? Toxicology 7:45-56.
108. Schwartz, E., J. A. Tornaben, et al. 1973. The effects of food restriction on hematology, clinical chemistry and pathology in the albino rat. Toxicol. Appl. Pharmacol. 25:515-524.
109. Selgrade, M. J., R. F. Lemarkski, M. I. Gilmour, L. M. Neas, M. D. Ward, P. K. Hennenberger, D. N. Weissman, J. A. Hoppin, R. R. Dietert, P. D. Sly, A. M. Geller, P. L. Enright, G. S. Backus, P. A. Bromberg, D. R. Germolec, and K. B. Yeatts. 2006. Induction of asthma and the environment: what we know and need to know. Environ. Health Perspect. 114:615-619.
110. Smith, A. H., G. Marshall, Y. Yuan, C. Ferreccio, J. Liaw, O. von Ehrenstein, C. Steinmaus, M. N. Bates, and S. Selvin. 2006. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ. Health Perspect. 114: 1293-1296.
111. Smyth, R. L. 2002. Asthma: a major pediatric health issue. Respir. Res. 3:S3-S7.
112. Suttie, A. W. 2007. Histopathology of the spleen. Toxicol. Pathol. 34:466-503.
113. Swartz, T. A., P. Saliou, E. Catznelson, C. Blondeau, I. Gil, T. Peled, O. Havkin, and M. Fletcher. 2003. Immune response to a diphtheria and tetanus toxoid administration in a three-dose diphtheria tetanus whole cell pertussis/enhanced inactivated poliovirus vaccination schedule: A 7-year follow-up. Eur. J. Epidemiol. 18:827-833.
114. Temple, L., T. T. Kawabata, A. E. Munson, and K. L. White Jr. 1993. Comparison of ELISA and plaque-forming cell assays for measuring the humoral immune response to SRBC in rats and mice treated with benzo(a)pyrene or cyclophosphamide. Fundam. Appl. Toxicol. 21:412-419.
115. Thurston, G. D., M. Lippmann, M. B. Scott, and J. M. Fine. 1997. Summertime haze air pollution and children with asthma. Am. J. Resp. Crit. Care Med. 155:654-660.
116. Timonen, K. L. and J. Pekkanen. 1997. Air pollution and respiratory health among children with asthmatic or cough symptoms. Am. J. Resp. Crit. Care Med. 156:546-552.
117. Travlos, G. S. 2007a. Normal structure, function, and histology of the bone marrow. Toxicol. Pathol. 34:548-565.
118. Travlos, G. S. 2007b. Histopathology of bone marrow. Toxicol. Pathol. 34:566-598.
119. Van Loveren, H., J. G. van Amsterdam, R. J. Vandebriel, T. G. Kimman, H. C. Rumke, P. S. Steerenberg, and J. G. Vos. 2001. Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors. Environ. Health Perspect. 109:757-764.
120. Van Loveren, H., J. Vos, E. Putman, and A. Piersma. 2003. Immunotoxicological consequences of perinatal chemical exposures:Aplea for inclusion of immune parameters in reproduction studies. Toxicol. Lett. 149:141-145.
121. Van Loveren, H. and A. Piersma. 2004. Immunotoxicological consequences of perinatal chemical exposures: a plea for inclusion of immune parameters in reproduction studies. Toxicol. Lett. 185:185-191.
122. von Ehrenstein, O. S., E. von Mutius, S. Illi, L. Baumann, O. Bohnand, and R. von Kries. 2000. Reduced risk of hayfever and astma among children of farmers. Clin. Exp. Allergy 30:187-193.
123. Ward, J. M., C. R. Erexson, L. J. Faucette, J. F. Foley, C. Dijkstra, and G. Cattoretti. 2007. Immunohistochemical markers for the rodent immune system. Toxicol. Pathol. 34:616-630.
124. Weisglas-Kuperus, N., S. Patandin, G. A. Berbers, T. C. Sas, P. G. Mulder, P. J. Sauer, and H. Hooijkaas. 2004. Immunological effects of environmental exposure to polychlorinated biphenyls and dioxins in Dutch school children. Toxicol. Lett. 149:281-285.
125. Weisglas-Kuperus, N., T. C. Sas, C. Koopman-Esseboom, C. W. van der Zwan, M. A. De Ridder, A. Beishuizen, H. Hooijkaas, and P. J. Sauer. 1995. Immunologic effects of background prenatal and postnatal exposure to dioxins and polychlorinated biphenyls in Dutch infants. Pediatr. Res. 28:404-410.
126. Weisglas-Kuperus, N., H. J. Vreugdenhil, and P. G. Mulder. 2000. Immunological effects of background exposure to polychlorinated biphenyls and dioxins in Dutch school children. Environ. Health Perspect. 108:1203-1207.
127. West, L. J. 2002. Defining critical windows in the development of the human immune system. Human Exp. Toxicol. 21:499-505.
128. Willard-Mack, C. L. 2007. Normal structure, function, and histology of lymph nodes. Toxicol. Pathol. 34:409-424.
129. Yeatts, Y., P. Sly, S. Shore, S. Weiss, F. Martinez, A. Geller, P. Bromberg, P. Enright, H. Koren, D. Weissman, and M. J. Selgrade. 2006. A brief targeted review of susceptibility factors, environmental exposures, asthma incidence, and recommendations for future asthma incidence research. Environ. Health Perspect. 114:634-640.
130. Yun, A. J., and P. Y. Lee. 2005. The link between T helper balance and lymphoproliferative disease. Med. Hypoth. 65:587-590.